<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01776489</url>
  </required_header>
  <id_info>
    <org_study_id>119/2011</org_study_id>
    <secondary_id>KLI 284-B00</secondary_id>
    <nct_id>NCT01776489</nct_id>
  </id_info>
  <brief_title>Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy</brief_title>
  <official_title>The Role of Sphingosine-1-phosphate in Food Allergy - Biomarker for Disease Severity and Anaphylaxis Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Food allergies represent an increasing health concern in the industrialized countries and
      especially affect pediatric patients. In this population adverse reactions against food
      compounds can lead to anaphylactic reactions. Despite substantial research efforts, clinical
      markers predicting disease severity and symptoms are missing to date.

      Recent studies have revealed that sphingolipids, especially sphingosine-1-phosphate (S1P),
      play an essential role in allergy. It was reported that asthmatic patients have higher S1P
      levels in bronchiallavage fluids after allergen challenge. First experimental studies
      revealed a correlation of S1P and the outcome of anaphylaxis. Furthermore, we have shown in
      our recent mouse study that S1P homeostasis is pivotal for food allergy induction and
      effector cell response. Therefore, it is the aim of the presented pilot project to evaluate
      whether S1P serum titers are altered in food allergic children and if the S1P levels
      correlate with the outcome of anaphylaxis during double blind placebo controlled food
      challenges (DBPCFCs).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>S1P in allergic and non-allergic patients before and after challenge</measure>
    <time_frame>up to 3 years</time_frame>
    <description>The primary endpoint of this study is the measurement of S1P in allergic and non-allergic patients before and after challenge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of allergic mediators and correlation with S1P levels</measure>
    <time_frame>up to 3 years</time_frame>
    <description>Evaluation of allergic mediators like histamine, human mast cell tryptase and eosinophil cationic protein and correlate these results with the levels of S1P within the group and between allergic and non-allergic patients</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Food Allergy</condition>
  <condition>Anaphylaxis</condition>
  <arm_group>
    <arm_group_label>food allergic</arm_group_label>
    <description>positive reaction during DBPCFC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-food allergic</arm_group_label>
    <description>no reaction during DBPCFC</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children (age 1-17 years) being in medical care at the allergy clinic of the Department of
        Pediatrics and Adolescent Medicine of the Medical University of Vienna for food related
        immediate type symptoms (nausea, abdominal pain, vomiting, diarrhea or local symptoms like
        burning, swelling, itching and erythema) immediately after ingestion of food compounds will
        be enrolled in this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 1-17 years who have been reported to suffer from food allergic
             reactions and who are subjected to DBPCFC or open provocation

          -  Patients who are diagnosed by elevated allergen specific IgE and/or positive skin
             prick testing

          -  Willingness to participate in the study

        Exclusion Criteria:

          -  Refusal to participate in the study

          -  Non-IgE-mediated food allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Untersmayr-Elsenhuber, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Vienna, Department of Pathophysiology and Allergy Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zsolt Szépfalusi, MD</last_name>
    <phone>+43 1 40400</phone>
    <phone_ext>3232</phone_ext>
    <email>zsolt.szepfalusi@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Susanne C. Diesner, MD, PhD</last_name>
    <phone>+43 1 40400</phone>
    <email>susanne.diesner@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University Vienna, Department of Pediatrics and Adolescent Medicine</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Zsolt Szépfalusi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <link>
    <url>http://www.meduniwien.ac.at/ipa</url>
    <description>study center</description>
  </link>
  <link>
    <url>http://www.meduniwien.ac.at/kinderklinik/</url>
    <description>study center</description>
  </link>
  <link>
    <url>http://www.gastrointestinal.at</url>
    <description>project homepage</description>
  </link>
  <reference>
    <citation>Diesner SC, Olivera A, Dillahunt S, Schultz C, Watzlawek T, Förster-Waldl E, Pollak A, Jensen-Jarolim E, Untersmayr E, Rivera J. Sphingosine-kinase 1 and 2 contribute to oral sensitization and effector phase in a mouse model of food allergy. Immunol Lett. 2012 Jan 30;141(2):210-9. doi: 10.1016/j.imlet.2011.10.006. Epub 2011 Oct 14. Erratum in: Immunol Lett. 2012 Aug 30;146(1-2):79.</citation>
    <PMID>22020265</PMID>
  </reference>
  <reference>
    <citation>Olivera A, Eisner C, Kitamura Y, Dillahunt S, Allende L, Tuymetova G, Watford W, Meylan F, Diesner SC, Li L, Schnermann J, Proia RL, Rivera J. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J Clin Invest. 2010 May;120(5):1429-40. doi: 10.1172/JCI40659. Epub 2010 Apr 19.</citation>
    <PMID>20407207</PMID>
  </reference>
  <reference>
    <citation>Olivera A, Mizugishi K, Tikhonova A, Ciaccia L, Odom S, Proia RL, Rivera J. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity. 2007 Mar;26(3):287-97. Epub 2007 Mar 8.</citation>
    <PMID>17346996</PMID>
  </reference>
  <reference>
    <citation>Ammit AJ, Hastie AT, Edsall LC, Hoffman RK, Amrani Y, Krymskaya VP, Kane SA, Peters SP, Penn RB, Spiegel S, Panettieri RA Jr. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 2001 May;15(7):1212-4.</citation>
    <PMID>11344091</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2013</study_first_submitted>
  <study_first_submitted_qc>January 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2013</study_first_posted>
  <last_update_submitted>December 9, 2015</last_update_submitted>
  <last_update_submitted_qc>December 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Eva Untersmayr-Elsenhuber</investigator_full_name>
    <investigator_title>Assoc. Prof., Dr.</investigator_title>
  </responsible_party>
  <keyword>Food allergy</keyword>
  <keyword>Sphingosine-1-phosphate</keyword>
  <keyword>Biomarker</keyword>
  <keyword>Double-blind placebo-controlled food challenge</keyword>
  <keyword>Anaphylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Food Hypersensitivity</mesh_term>
    <mesh_term>Anaphylaxis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

